Boston Scientific Corp.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-1.03B | $-2.04B | $-495.0M |
| Depreciation & Amortization | $834.0M | $864.0M | $918.0M |
| Depreciation | $323.0M | $321.0M | — |
| Amortization | $511.0M | $543.0M | $620.0M |
| Stock-Based Compensation | $144.0M | $138.0M | $122.0M |
| Net Cash from Operating Activities | $835.0M | $1.22B | $934.0M |
| Investing Activities | |||
| Capital Expenditures | $312.0M | $362.0M | $363.0M |
| Business Acquisitions | $4.0M | $21.0M | $13.0M |
| Net Cash from Investing Activities | $-793.0M | $324.0M | $-474.0M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $-820.0M | $-1.35B | $-680.0M |
| Net Change in Cash | $-777.0M | $189.0M | $-216.0M |
| Free Cash Flow | $523.0M | $854.0M | $571.0M |